Effect of continuous versus cyclic dosing regimen of hormonal contraception on bleeding pattern, cardivascular risk marker, sexual function and satisfactio

• Conditions: The study aims to evaluate the bleeding pattern, side-effects, cardiovascular riskmarker, sexual function and user-satisfaction when combined contraceptive hormonal methods are being administered continuously without hormonfree intervals. The products to be studied are since long marketed and frequently used and studied during cyclic use; MedDRA version: 9.1Level: LLTClassification code 10010808Term: Contraception

• Registration Number: EUCTR2006-003636-30-SE
• Lead Sponsor: Karolinska University Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2008-01-28
• Last Update Posted: 19 March 2012

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: Female
• Target Recruitment: Not specified

Inclusion Criteria

Healthy fertile women between 18 and 45 years of age.
Desire for a hormonal contraceptive method.
Willing to participate in the study for 12 months
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Any contraindication for estrogen containing treatment.
Regular medication with non-steroid anti-inflammatory drugs

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified